MUDr. Kanderkova s.r.o.
- Address
- lock Available on a paid plan
Cardiovascular Diseases
The outpatient diabetology and metabolic disorders department at MUDr. Kanderkova s.r.o. concentrates on research in cardiovascular disease, with special attention to cholesterol‑related conditions.
- Atherosclerotic cardiovascular disease
- Hyperlipidemia
- LDL‑C lowering therapies
Ongoing studies assess the safety and effectiveness of a new compound, AZD0780, designed to lower LDL‑C in adults at risk for heart attack, stroke, or other vascular events, aiming to improve preventive care.
Clinical Research Overview
At this Slovakian site, investigators are exploring therapeutic options for patients with high “bad” cholesterol and associated vascular risk.
- Risk reduction for atherosclerotic disease
- Management of elevated lipid levels
- Evaluation of novel lipid‑lowering agents
The research program, based in Namestovo, benefits from focused patient care and close monitoring by a dedicated clinical investigator.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1AstraZeneca AB2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in MUDr. Kanderkova s.r.o.
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Baxdrostat and Dapagliflozin on Heart Failure Incidence and Cardiovascular Mortality in High-Risk Patients: A Phase III Randomized Controlled Trial | AstraZeneca AB | Phase III | Recruiting | May 2025 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin | 2 | Unknown | 2025-05-06 | 2025-05-06 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.